Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter''s Five Force Analysis
- Genome Editing/Genome Engineering Market, By Application
5.1 Introduction
5.2 Genetic Engineering
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Other Applications
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Cell Line Engineering
5.4.1 Market Overview
5.4.2 Market Size and Forecast
- Genome Editing/Genome Engineering Market, By End User
6.1 Introduction
6.2 Academic & Research Institutions
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Contract Research Organization
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Biotechnology & Pharmaceutical Companies
6.4.1 Market Overview
6.4.2 Market Size and Forecast
- Genome Editing/Genome Engineering Market, By Technology
7.1 Introduction
7.2 ZFN
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Antisense
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Other Technologies
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 CRISPR
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Talen
7.6.1 Market Overview
7.6.2 Market Size and Forecast
- Genome Editing/Genome Engineering Market, By Geography
8.1 Introduction
8.2 Europe
8.2.1 Europe Market, By Application
8.2.2 Europe Market, By End User
8.2.3 Europe Market, By Technology
8.3 North America
8.3.1 North America Market, By Application
8.3.2 North America Market, By End User
8.3.3 North America Market, By Technology
8.4 Asia Pacific
8.4.1 Asia Pacific Market, By Application
8.4.2 Asia Pacific Market, By End User
8.4.3 Asia Pacific Market, By Technology
8.5 Rest of The World
8.5.1 Rest of The World Market, By Application
8.5.2 Rest of The World Market, By End User
8.5.3 Rest of The World Market, By Technology
- Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
- Company Profiles
10.1 Integrated Dna Technologies
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Lonza
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 New England Biolabs
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Origene Technologies
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Transposagen Biopharmaceuticals
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Thermo Fisher Scientific
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Merck
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Horizon Discovery Group
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Genscript
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Sangamo Biosciences
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments